$3.12
▼ $-0.01
(-0.32%)
Vol 686K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$218.8M
ROE
-63.0%
D/E
0.00
Beta
0.34
52W
$1–$11
Wall Street Consensus
16 analysts · Apr 20265
Strong Buy
6
Buy
5
Hold
0
Sell
0
Strong Sell
68.8%
Buy Rating
Price Chart
Similar Stocks
SRZN
Surrozen Inc
$193.7M
GLSI
Greenwich Lifesciences Inc
$291.1M
PALI
Palisade Bio Inc
$350.2M
CLYM
Climb Bio Inc
$272.7M
OVID
Ovid Therapeutics Inc
$116.1M
FHTX
Foghorn Therapeutics Inc
$305.4M
ORGO
Organogenesis Holdings Inc
P/E 654.1
$657.4M
NBP
NovaBridge Biosciences
$458.9M
AVXL
Anavex Life Sciences Corp
$318.1M
TARA
Protara Therapeutics Inc
$275.2M
Earnings
Beat rate: 25.0%
Next Report
May 11, 2026
EPS Estimate: $-0.18
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2026 | $-0.18 | — | — |
| Dec 2025 | $-0.19 | $-0.22 | $-0.03 |
| Sep 2025 | $-0.27 | $-0.18 | +$0.09 |
| Jun 2025 | $-0.22 | $-0.26 | $-0.04 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -64.9% | -70.1% | -65.0% | -65.0% | -63.0% | -63.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 14.37 | 8.43 | 14.37 | 14.37 | 15.15 | 15.15 |
Key Ratios
ROA (TTM)
-57.3%
P/B
2.4
EPS (TTM)
$-0.93
CF/Share
$-1.10
52W High
$11.46
52W Low
$1.07
$1.07
52-Week Range
$11.46
How does RZLT compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
RZLT valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.4
▼
3%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
RZLT profitability vs Biotechnology peers
ROE
-63.0%
▲
6%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-57.3%
▼
23%
below
peers
(-46.7%)
vs Peers
vs Industry
Below avg
RZLT financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
15.2
▲
241%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.3
▼
65%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
RZLT fundamentals radar
RZLT
Peer median
Industry
RZLT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RZLT vs peers: key metrics
Latest News
No related news yet